Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarter

Explore Business Standard
Associate Sponsors
Co-sponsor

Sales rise 57.04% to Rs 159.93 crore
Net profit of Fredun Pharmaceuticals rose 96.62% to Rs 10.48 crore in the quarter ended December 2025 as against Rs 5.33 crore during the previous quarter ended December 2024. Sales rose 57.04% to Rs 159.93 crore in the quarter ended December 2025 as against Rs 101.84 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales159.93101.84 57 OPM %16.4612.98 -PBDT15.788.22 92 PBT14.007.13 96 NP10.485.33 97Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Feb 13 2026 | 12:17 PM IST